![]() |
市場調查報告書
商品編碼
1504234
人工水晶體的市場規模,佔有率,預測,趨勢分析,各類型,各材料,各用途,各終端用戶-2031年為止的全球預測Intraocular Lens Market Size, Share, Forecast, & Trends Analysis by Type (Monofocal, Multifocal, Toric, Phakic) Material (Hydrophobic Acrylic, PMMA, Silicone) Application (Cataract, Astigmatism, Corneal Disorders) End User - Global Forecast to 2031 |
人工水晶體市場預計到 2031 年將達到 71.7 億美元,2024 年至 2031 年複合年增長率為 6.5%。
該報告基於全面的一手和二手研究以及對市場情景的深入分析,提供了該行業的關鍵驅動因素、限制因素、課題和機遇。該市場的推動因素包括老年人口數量的增加、白內障手術數量的增加、過度使用數位設備導致的視力障礙以及政府為改善眼部保健服務的可及性而採取的舉措和資金。
此外,人們對微創眼科手術的日益青睞正在為該市場創造巨大的成長機會。然而,人工水晶體的高成本和報銷政策的缺乏可能會限製成長。此外,人工水晶體的罕見併發症給該市場的參與者帶來了課題。
(註:為前 5 名公司提供 SWOT 分析)
Intraocular Lens Market Size, Share, Forecast, & Trends Analysis by Type (Monofocal, Multifocal, Toric, Phakic) Material (Hydrophobic Acrylic, PMMA, Silicone) Application (Cataract, Astigmatism, Corneal Disorders) End User-Global Forecast to 2031
The intraocular lens market is projected to reach $7.17 billion by 2031, at a CAGR of 6.5% from 2024 to 2031.
Following a comprehensive primary and secondary study and an in-depth analysis of the market scenario, this report provides the key drivers, constraints, challenges, and opportunities of the industry. This market is driven by the rising geriatric population, increasing number of cataract surgeries, visual impairment due to excessive use of digital devices, and government initiatives and funding to improve accessibility to eye care services.
Furthermore, the rising preference for minimally invasive ophthalmic surgeries provides a significant growth opportunity for this market. However, the high costs of intraocular lenses and the unavailability of reimbursement policies may restrain its growth. Additionally, rare complications of IOL pose a challenge for the players operating in this market.
Among types, in 2024, the multifocal intraocular lenses segment is expected to account for the largest share of 28.9% of the intraocular lens market. The large share of the segment is attributed to factors such as proven/predictable results, cost-effectiveness, minimum maintenance, and the high prevalence of cataracts in older people. The key market players are undertaking various strategic initiatives to innovate multifocal intraocular lenses. For instance, in July 2022, Lenstec, Inc. (U.S.) received U.S. Food and Drug Administration (FDA) approval for the SBL-3 Multifocal Intraocular Lens (IOL), which is permanently implanted inside the eye. The SBL-3 is a multifocal intraocular lens with two zones that focus light-one from objects far away (distance vision) and the other from objects close up (near vision).
Among materials, in 2024, the hydrophobic acrylic segment is expected to account for the largest share of the intraocular lens market. Hydrophobic acrylic is the most commonly used type of material in IOLs. This material is composed of crosslinked copolymers of acrylic esters and other acrylic ester co-monomers, with a carbon backbone and ester side groups. The large share of the segment is attributed to factors such as the increasing popularity of ophthalmologists, good mechanical stability, good uveal biocompatibility, ease of manufacturing, and lower rates of complications in IOL.
Among applications, in 2024, the cataract surgery segment is expected to account for the largest share of the intraocular lens market. The large share of the segment is attributed to factors such as the increasing number of cataract surgeries, growing demand for intraocular lenses, and increasing technological advancements in intraocular lenses.
Among end users, in 2024, the hospitals products segment is expected to account for the largest share of the intraocular lens market. The large share of the market is attributed to factors such as the increasing prevalence of eye diseases and disorders and increasing awareness of ocular diseases leading to rising visits to hospitals.
An in-depth analysis of the geographical scenario of the intraocular lens market provides detailed qualitative and quantitative insights for the five major geographies (North America, Europe, Asia-Pacific, the Middle East & Africa, and Latin America) along with the coverage of major countries in each region. In 2024, Asia-Pacific is slated to register the highest CAGR of 8.5% of the intraocular lens market. The high growth of the segment is primarily attributed to the rising geriatric population in countries such as China and India, the adoption of advanced healthcare resources, and rising awareness regarding the benefits of vision care products. Furthermore, the increasing affordability and availability of vision treatment providers also contribute to the growth of this market.
The key players operating in the intraocular lens market are Alcon, Inc. (U.S.), Johnson & Johnson Services, Inc. (U.S.), Carl Zeiss Meditec AG (Germany), Hoya Corporation (Japan), Beaver-Visitec International (U.S.), Ophtec B.V. (Netherlands), Appasamy Associates Private Limited (India), Atia Vision, Inc. (U.S.), LENSTEC, Inc. (U.S.), Santen Pharmaceutical Co., Ltd. (Japan), Rayner Group (U.K.), EyeKon Medical, Inc. (U.S.), and Humanoptics Holding AG (Germany).
Intraocular Lens Market-by Type
(Other lenses include extended depth-of-focus (EDOF) lenses and light adjustable lenses, among others)
Intraocular Lens Market-by Material
(Other materials include Collamer (Collagen+Polymer) and PEG-PHS/HEMA/Styrene (PHS) Copolymer, among others)
Intraocular Lens Market-by Application
(Other applications include presbyopia, nearsightedness, and farsightedness)
Intraocular Lens Market-by End User
Intraocular Lens Market-by Geography
(Note: SWOT analysis of the top 5 companies is provided.)